Association study of interleukin-19 rs2243188 polymorphism with systemic lupus erythematosus in a Chinese population

References

• Wang, J., H. F. Pan, H. Su, et al. 2009. Tuberculosis in systemic lupus erythematosus in Chinese patients. Trop. Doct. 39: 165–167
   PubMed Web of Science ®Google Scholar
• Cen, H., W. Wang, R. X. Leng, et al. 2013. Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune disease: a meta-analysis. Autoimmunity 46: 455–462
   PubMed Web of Science ®Google Scholar
• Chung, S. A., K. E. Taylor, R. R. Graham, et al. 2011. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet. 7: e1001323
   PubMed Web of Science ®Google Scholar
• Wakeland, E. K., K. Liu, R. R. Graham, and T. W. Behrens. 2001. Delineating the genetic basis review of systemic lupus erythematosus. Immunity 15: 397–408
   PubMed Web of Science ®Google Scholar
• Commins, S., J. W. Steinke, and L. Borish. 2008. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J. Allergy. Clin. Immunol. 121: 1108–1111
   PubMed Web of Science ®Google Scholar
• Liao, Y. C., W. G. Liang, F. W. Chen, et al. 2002. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J. Immunol. 169: 4288–4297
   PubMed Web of Science ®Google Scholar
• Liao, S. C., Y. C. Cheng, Y. C. Wang, et al. 2004. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J. Immunol. 173: 6712–6718
   PubMed Web of Science ®Google Scholar
• Dumoutier, L., C. Leemans, D. Lejeune, et al. 2001. Cutting Edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol. 167: 3545–3549
   PubMed Web of Science ®Google Scholar
• Fielding, C. A. 2012. Interleukin-19: a new target to aim for? Rheumatology (Oxford) 51: 399–400
   PubMed Web of Science ®Google Scholar
• Huang, F., S. Wachi, P. Thai, et al. 2008. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J. Allergy Clin. Immunol. 121: 1415–1421
   PubMedGoogle Scholar
• Sakurai, N., T. Kuroiwa, H. Ikeuchi, et al. 2008. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 47: 815–820
   PubMed Web of Science ®Google Scholar
• Yamamoto-Furusho, J. K., E. Alvarez-Leon, J. M. Fragoso, et al. 2011. Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis. Hum. Immunol. 72: 1029–1032
   PubMed Web of Science ®Google Scholar
• Kõks, S., K. Kingo, R. Rätsep, et al. 2004. Combined haplotype analysis of the interleukin-19 and 20 genes: relationship to plaque-type psoriasis. Genes Immun. 5: 662–667
   PubMed Web of Science ®Google Scholar
• Kingo, K., E. Reimann, M. Karelson, et al. 2010. Association analysis of genes of the IL-19 cluster and their receptors in vitiligo patients. Dermatology 221: 261–266
   PubMed Web of Science ®Google Scholar
• Hochberg, M. C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40: 1725
   PubMed Web of Science ®Google Scholar
• Tan, E. M., A. S. Cohen, J. F. Fries, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Liu, P., J. Song, H. Su, et al. 2013. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS One. 8: e69547
   PubMedGoogle Scholar
• Yu, B., M. Guan, Y. Peng, et al. 2011. Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus. Arthritis Rheum. 63: 3487–3492
   PubMed Web of Science ®Google Scholar
• Li, H. H., Y. C. Lin, P. J. Chen, et al. 2005. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br. J. Dermatol. 153: 591–595
   PubMed Web of Science ®Google Scholar
• Azuma, Y. H., Y. Matsuo, M. Kuwamura, et al. 2010. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm. Bowel. Dis. 16: 1017–1028
   PubMed Web of Science ®Google Scholar
• Hsing, C. H., C. C. Hsu, W. Y. Chen, et al. 2007. Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol. Dial. Transplant. 22: 2230–2238
   PubMed Web of Science ®Google Scholar
• Gabunia, K., S. Jain, R. N. England, and M. V. Autieri. 2011. Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am. J. Physiol. Cell. Physiol. 300: C896–C906
   Web of Science ®Google Scholar
• Jordan, W. J., J. Eskdale, M. Boniotto, et al. 2005. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur. J. Immunol. 35: 1576–1582
   PubMed Web of Science ®Google Scholar
• Hsu, Y. H., H. H. Li, J. M. Sung, et al. 2013. Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury. PLoS One 8: e56028
   Web of Science ®Google Scholar
• Noris, M., S. Bernasconi, F. Casiraghi, et al. 1995. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab. Invest. 73: 804–809
   PubMed Web of Science ®Google Scholar